Sociedad Americana de Hirudoterapia

434 Salivary Proteins — Integrated Proteomics of Hirudo medicinalis

The most comprehensive catalog of leech salivary bioactive compounds

Genomics & ProteomicsLiu et al. (2019)Journal of ProteomicsDOI →

Why this matters for hirudotherapy

Vastly expanded the known bioactive molecule catalog from ~20 classically characterized compounds to 434+. Provides the foundation for modern drug discovery from the leech secretome and explains the multi-target therapeutic mechanism.

Investigational / Research Priority

Investigación en ciencia básica. Esta revisión cubre hallazgos de proteómica y transcriptómica sin aplicación clínica directa en esta etapa.

Last Updated: March 5, 2026Reviewed by: Andrei Dokukin, MD

De 20 compuestos a 434 proteínas

For over a century, our understanding of leech SGSry composition was limited to approximately 20 compounds isolated through classical biochemistry — hirudin, calin, destabilase, hyaluronidase, bdellins, and eglins being the best characterized. Liu et al. (2019) transformed this picture using integrated proteomics and transcriptomics, revealing that the medicinal leech secretome is vastly more complex than previously understood.[R1]

Metodología

The study combined two complementary omics approaches:

Proteomics (protein-level)

Liquid chromatography–tandem mass spectrometry (LC-MS/MS) of salivary gland secretions identified 434 full-length protein sequences, of which 44 were confirmed as bioactive through functional annotation.

Transcriptomics (RNA-level)

RNA sequencing of salivary gland tissue identified 221 bioactive transcripts, providing evidence that the gland actively expresses a vast repertoire of functional molecules beyond what had been characterized.

[R1]

Seis categorías funcionales

The 434 identified proteins were classified into six major functional groups, revealing the multi-target nature of leech SGS:

Anticoagulants

Thrombin inhibitors (hirudin variants), Factor Xa inhibitors, fibrinolytic enzymes. The primary functional group responsible for the sustained bleeding effect.

Anti-platelet

Platelet aggregation inhibitors (calin, saratin) and collagen adhesion blockers. Prevent primary hemostasis at the bite wound.

Vasodilators

Histamine-like compounds, acetylcholine, and vasodilatory peptides that increase local blood flow to the feeding site.

Anti-inflammatory

Proteinase inhibitors (bdellins, eglins), complement inhibitors, and immune modulators that suppress the host inflammatory response.

Analgesic

Anesthetic and analgesic compounds that reduce pain at the bite site — explaining why patients often do not feel the initial attachment.

Antimicrobial

Antimicrobial peptides (theromacin, destabilase-lysozyme, hirunipins) that protect the wound environment from secondary infection.

[R1]

Impacto cuantitativo

434

Proteins identified

44

Confirmed bioactive

221

Bioactive transcripts

6

Functional categories

Por qué esto importa para la hirudoterapia

The Liu et al. study fundamentally changed our understanding of how leech therapy works. Instead of a simple anticoagulant effect (the hirudin-centric model), we now understand that the leech delivers a coordinated multi-target pharmacological cocktail — simultaneously acting on coagulation, platelets, vasculature, inflammation, pain, and infection. This multi-target mechanism may explain the broad therapeutic effects observed clinically, including the prolonged pain relief seen in osteoarthritis trials.[R1]

The dataset also provides a rich source for drug discovery: the vast majority of the 434 proteins remain uncharacterized for therapeutic potential, representing a largely untapped pharmacological resource.[R2][R3]

Complementary genomic data

El ensamblaje genómico de Kvist et al. (2020) proporciona el marco genómico que complementa este catálogo proteómico. Juntos, estos dos estudios forman la base de la bioprospección moderna de sanguijuelas — permitiendo la identificación de nuevos compuestos a nivel de gen, transcrito y proteína simultáneamente.

References

  • [R1]

    Integrated Proteomics and Transcriptomics of Hirudo medicinalis Salivary Gland Secretion

    Primary source. First integrated multi-omics study of leech salivary glands.

  • [R2]

    A Chromosome-Level Genome Assembly for the Medicinal Leech and Identification of Anticoagulant Genes

    Kvist et al. genome assembly complementing the proteomics data.

  • [R3]

    Comparative Transcriptomics of Three Hirudo Species: Insights into Evolution of Salivary Proteins

    Babenko et al. cross-species comparison of salivary transcriptomes.

Recursos relacionados

Added to ASH library: February 27, 2026 | Site last updated: March 14, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.